{"nct_id":"NCT03234972","title":"A Study to Compare Daratumumab, Bortezomib, and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in Chinese Participants With Relapsed or Refractory Multiple Myeloma","status":"COMPLETED","status_verified_date":"2024-05","start_date":"2017-11-30","start_date_type":"ACTUAL","primary_completion_date":"2019-10-07","primary_completion_date_type":"ACTUAL","completion_date":"2024-02-27","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["JNJ"]}